Anticoagulants Market 2028 By Drug Class, Route Of Administration, Application, Distribution Channel and Geography | The Insight Partners

Anticoagulants Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Class (Novel oral anticoagulants (NOACs), Heparin and Low-molecular-weight heparin (LMWH), Vitamin K Antagonist, Others); Route Of Administration (Oral anticoagulant, Injectable anticoagulant); Application (Atrial fibrillation and Heart Attack, Stroke, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography

Report Code: TIPRE00004062 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

MARKET OVERVIEW



Anticoagulant drugs (sometimes called blood thinners) are chemical substances that prevent or decrease blood coagulation and prolong the time it takes for blood to clot. These drugs are primarily used to prevent blood clots in patients with atrial fibrillation, deep vein thrombosis, myocardial infarction, pulmonary embolism, stroke, and other medical conditions. The global anticoagulants market is expected to rise significantly over the forecast period, in respect to growing prevalence of venous thromboembolism (VTE) and cardiovascular disorders, increased adoption of novel oral anticoagulants (NOACs), and rising awareness of NOACs in developing countries.

MARKET SCOPE



The "Global Anticoagulants Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the anticoagulants market with detailed market segmentation by drug class, route of administration, application and distribution channel. The report provides key statistics on the market status of the leading anticoagulants market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION



  • Based on drug class the market is segmented as, novel oral anticoagulants (NOACs), heparin & low-molecular-weight heparin (LMWH), vitamin K antagonist and others.
  • Based on route of administration the market is segmented as, oral anticoagulant and injectable anticoagulant.
  • Based on application the market is segmented as, atrial fibrillation & heart attack, stroke, deep vein thrombosis (DVT), pulmonary embolism (PE) and others.
  • Based on distribution channel the market is segmented as, hospital pharmacies, retail pharmacies and online pharmacies.

MARKET DYNAMICS


Drivers:



  • Growing prevalence of venous thromboembolism (VTE) and cardiovascular disorders.
  • Increased adoption of novel oral anticoagulants (NOACs), and rising awareness of NOACs in developing countries.
  • Surge in demand for novel therapeutics along with growing elderly population are also expected to fuel the market growth.

Restraints:



  • However, stringent regulatory approvals and chances of side effects from treatment are expect to restrain market growth during the forecast period.

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The anticoagulants market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the anticoagulants market in these regions.

IMPACT OF COVID-19 ON ANTICOAGULANTS MARKET



COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS



The report covers key developments in the anticoagulants market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from anticoagulants market are anticipated to lucrative growth opportunities in the future with the rising demand for anticoagulants in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the anticoagulants market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline plc.
  • Pfizer, Inc.
  • Sanofi
  • Aspen Holdings
  • Janssen Pharmaceuticals, Inc
  • Boehringer Ingelheim International GmbH
  • DAIICHI SANKYO COMPANY, LIMITED
  • Alexion Pharmaceuticals, Inc
  • Bayer AG
    The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
  • TABLE OF CONTENTS

    1. INTRODUCTION
    1.1. SCOPE OF THE STUDY
    1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
    1.3. MARKET SEGMENTATION
    1.3.1 Anticoagulants Market - By Drug Class
    1.3.2 Anticoagulants Market - By Route Of Administration
    1.3.3 Anticoagulants Market - By Application
    1.3.4 Anticoagulants Market - By Distribution Channel
    1.3.5 Anticoagulants Market - By Region
    1.3.5.1 By Country

    2. KEY TAKEAWAYS

    3. RESEARCH METHODOLOGY

    4. ANTICOAGULANTS MARKET LANDSCAPE
    4.1. OVERVIEW
    4.2. PORTER'S FIVE FORCES ANALYSIS
    4.2.1 Bargaining Power of Buyers
    4.2.1 Bargaining Power of Suppliers
    4.2.1 Threat of Substitute
    4.2.1 Threat of New Entrants
    4.2.1 Competitive Rivalry
    4.3. EXPERT OPINIONS

    5. ANTICOAGULANTS MARKET - KEY MARKET DYNAMICS
    5.1. KEY MARKET DRIVERS
    5.2. KEY MARKET RESTRAINTS
    5.3. KEY MARKET OPPORTUNITIES
    5.4. FUTURE TRENDS
    5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

    6. ANTICOAGULANTS MARKET - GLOBAL MARKET ANALYSIS
    6.1. ANTICOAGULANTS - GLOBAL MARKET OVERVIEW
    6.2. ANTICOAGULANTS - GLOBAL MARKET AND FORECAST TO 2028
    6.3. MARKET POSITIONING/MARKET SHARE

    7. ANTICOAGULANTS MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
    7.1. OVERVIEW
    7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
    7.3. NOVEL ORAL ANTICOAGULANTS (NOACS)
    7.3.1. Overview
    7.3.2. Novel oral anticoagulants (NOACs) Market Forecast and Analysis
    7.4. HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN (LMWH)
    7.4.1. Overview
    7.4.2. Heparin and Low-molecular-weight heparin (LMWH) Market Forecast and Analysis
    7.5. VITAMIN K ANTAGONIST
    7.5.1. Overview
    7.5.2. Vitamin K Antagonist Market Forecast and Analysis
    7.6. OTHERS
    7.6.1. Overview
    7.6.2. Others Market Forecast and Analysis
    8. ANTICOAGULANTS MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
    8.1. OVERVIEW
    8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
    8.3. ORAL ANTICOAGULANT
    8.3.1. Overview
    8.3.2. Oral anticoagulant Market Forecast and Analysis
    8.4. INJECTABLE ANTICOAGULANT
    8.4.1. Overview
    8.4.2. Injectable anticoagulant Market Forecast and Analysis
    9. ANTICOAGULANTS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
    9.1. OVERVIEW
    9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
    9.3. ATRIAL FIBRILLATION AND HEART ATTACK
    9.3.1. Overview
    9.3.2. Atrial fibrillation and Heart Attack Market Forecast and Analysis
    9.4. STROKE
    9.4.1. Overview
    9.4.2. Stroke Market Forecast and Analysis
    9.5. DEEP VEIN THROMBOSIS (DVT)
    9.5.1. Overview
    9.5.2. Deep Vein Thrombosis (DVT) Market Forecast and Analysis
    9.6. PULMONARY EMBOLISM (PE)
    9.6.1. Overview
    9.6.2. Pulmonary Embolism (PE) Market Forecast and Analysis
    9.7. OTHERS
    9.7.1. Overview
    9.7.2. Others Market Forecast and Analysis
    10. ANTICOAGULANTS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
    10.1. OVERVIEW
    10.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
    10.3. HOSPITAL PHARMACIES
    10.3.1. Overview
    10.3.2. Hospital Pharmacies Market Forecast and Analysis
    10.4. RETAIL PHARMACIES
    10.4.1. Overview
    10.4.2. Retail Pharmacies Market Forecast and Analysis
    10.5. ONLINE PHARMACIES
    10.5.1. Overview
    10.5.2. Online Pharmacies Market Forecast and Analysis

    11. ANTICOAGULANTS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
    11.1. NORTH AMERICA
    11.1.1 North America Anticoagulants Market Overview
    11.1.2 North America Anticoagulants Market Forecasts and Analysis
    11.1.3 North America Anticoagulants Market Forecasts and Analysis - By Drug Class
    11.1.4 North America Anticoagulants Market Forecasts and Analysis - By Route Of Administration
    11.1.5 North America Anticoagulants Market Forecasts and Analysis - By Application
    11.1.6 North America Anticoagulants Market Forecasts and Analysis - By Distribution Channel
    11.1.7 North America Anticoagulants Market Forecasts and Analysis - By Countries
    11.1.7.1 United States Anticoagulants Market
    11.1.7.1.1 United States Anticoagulants Market by Drug Class
    11.1.7.1.2 United States Anticoagulants Market by Route Of Administration
    11.1.7.1.3 United States Anticoagulants Market by Application
    11.1.7.1.4 United States Anticoagulants Market by Distribution Channel
    11.1.7.2 Canada Anticoagulants Market
    11.1.7.2.1 Canada Anticoagulants Market by Drug Class
    11.1.7.2.2 Canada Anticoagulants Market by Route Of Administration
    11.1.7.2.3 Canada Anticoagulants Market by Application
    11.1.7.2.4 Canada Anticoagulants Market by Distribution Channel
    11.1.7.3 Mexico Anticoagulants Market
    11.1.7.3.1 Mexico Anticoagulants Market by Drug Class
    11.1.7.3.2 Mexico Anticoagulants Market by Route Of Administration
    11.1.7.3.3 Mexico Anticoagulants Market by Application
    11.1.7.3.4 Mexico Anticoagulants Market by Distribution Channel
    11.2. EUROPE
    11.2.1 Europe Anticoagulants Market Overview
    11.2.2 Europe Anticoagulants Market Forecasts and Analysis
    11.2.3 Europe Anticoagulants Market Forecasts and Analysis - By Drug Class
    11.2.4 Europe Anticoagulants Market Forecasts and Analysis - By Route Of Administration
    11.2.5 Europe Anticoagulants Market Forecasts and Analysis - By Application
    11.2.6 Europe Anticoagulants Market Forecasts and Analysis - By Distribution Channel
    11.2.7 Europe Anticoagulants Market Forecasts and Analysis - By Countries
    11.2.7.1 Germany Anticoagulants Market
    11.2.7.1.1 Germany Anticoagulants Market by Drug Class
    11.2.7.1.2 Germany Anticoagulants Market by Route Of Administration
    11.2.7.1.3 Germany Anticoagulants Market by Application
    11.2.7.1.4 Germany Anticoagulants Market by Distribution Channel
    11.2.7.2 France Anticoagulants Market
    11.2.7.2.1 France Anticoagulants Market by Drug Class
    11.2.7.2.2 France Anticoagulants Market by Route Of Administration
    11.2.7.2.3 France Anticoagulants Market by Application
    11.2.7.2.4 France Anticoagulants Market by Distribution Channel
    11.2.7.3 Italy Anticoagulants Market
    11.2.7.3.1 Italy Anticoagulants Market by Drug Class
    11.2.7.3.2 Italy Anticoagulants Market by Route Of Administration
    11.2.7.3.3 Italy Anticoagulants Market by Application
    11.2.7.3.4 Italy Anticoagulants Market by Distribution Channel
    11.2.7.4 Spain Anticoagulants Market
    11.2.7.4.1 Spain Anticoagulants Market by Drug Class
    11.2.7.4.2 Spain Anticoagulants Market by Route Of Administration
    11.2.7.4.3 Spain Anticoagulants Market by Application
    11.2.7.4.4 Spain Anticoagulants Market by Distribution Channel
    11.2.7.5 United Kingdom Anticoagulants Market
    11.2.7.5.1 United Kingdom Anticoagulants Market by Drug Class
    11.2.7.5.2 United Kingdom Anticoagulants Market by Route Of Administration
    11.2.7.5.3 United Kingdom Anticoagulants Market by Application
    11.2.7.5.4 United Kingdom Anticoagulants Market by Distribution Channel
    11.2.7.6 Rest of Europe Anticoagulants Market
    11.2.7.6.1 Rest of Europe Anticoagulants Market by Drug Class
    11.2.7.6.2 Rest of Europe Anticoagulants Market by Route Of Administration
    11.2.7.6.3 Rest of Europe Anticoagulants Market by Application
    11.2.7.6.4 Rest of Europe Anticoagulants Market by Distribution Channel
    11.3. ASIA-PACIFIC
    11.3.1 Asia-Pacific Anticoagulants Market Overview
    11.3.2 Asia-Pacific Anticoagulants Market Forecasts and Analysis
    11.3.3 Asia-Pacific Anticoagulants Market Forecasts and Analysis - By Drug Class
    11.3.4 Asia-Pacific Anticoagulants Market Forecasts and Analysis - By Route Of Administration
    11.3.5 Asia-Pacific Anticoagulants Market Forecasts and Analysis - By Application
    11.3.6 Asia-Pacific Anticoagulants Market Forecasts and Analysis - By Distribution Channel
    11.3.7 Asia-Pacific Anticoagulants Market Forecasts and Analysis - By Countries
    11.3.7.1 Australia Anticoagulants Market
    11.3.7.1.1 Australia Anticoagulants Market by Drug Class
    11.3.7.1.2 Australia Anticoagulants Market by Route Of Administration
    11.3.7.1.3 Australia Anticoagulants Market by Application
    11.3.7.1.4 Australia Anticoagulants Market by Distribution Channel
    11.3.7.2 China Anticoagulants Market
    11.3.7.2.1 China Anticoagulants Market by Drug Class
    11.3.7.2.2 China Anticoagulants Market by Route Of Administration
    11.3.7.2.3 China Anticoagulants Market by Application
    11.3.7.2.4 China Anticoagulants Market by Distribution Channel
    11.3.7.3 India Anticoagulants Market
    11.3.7.3.1 India Anticoagulants Market by Drug Class
    11.3.7.3.2 India Anticoagulants Market by Route Of Administration
    11.3.7.3.3 India Anticoagulants Market by Application
    11.3.7.3.4 India Anticoagulants Market by Distribution Channel
    11.3.7.4 Japan Anticoagulants Market
    11.3.7.4.1 Japan Anticoagulants Market by Drug Class
    11.3.7.4.2 Japan Anticoagulants Market by Route Of Administration
    11.3.7.4.3 Japan Anticoagulants Market by Application
    11.3.7.4.4 Japan Anticoagulants Market by Distribution Channel
    11.3.7.5 South Korea Anticoagulants Market
    11.3.7.5.1 South Korea Anticoagulants Market by Drug Class
    11.3.7.5.2 South Korea Anticoagulants Market by Route Of Administration
    11.3.7.5.3 South Korea Anticoagulants Market by Application
    11.3.7.5.4 South Korea Anticoagulants Market by Distribution Channel
    11.3.7.6 Rest of Asia-Pacific Anticoagulants Market
    11.3.7.6.1 Rest of Asia-Pacific Anticoagulants Market by Drug Class
    11.3.7.6.2 Rest of Asia-Pacific Anticoagulants Market by Route Of Administration
    11.3.7.6.3 Rest of Asia-Pacific Anticoagulants Market by Application
    11.3.7.6.4 Rest of Asia-Pacific Anticoagulants Market by Distribution Channel
    11.4. MIDDLE EAST AND AFRICA
    11.4.1 Middle East and Africa Anticoagulants Market Overview
    11.4.2 Middle East and Africa Anticoagulants Market Forecasts and Analysis
    11.4.3 Middle East and Africa Anticoagulants Market Forecasts and Analysis - By Drug Class
    11.4.4 Middle East and Africa Anticoagulants Market Forecasts and Analysis - By Route Of Administration
    11.4.5 Middle East and Africa Anticoagulants Market Forecasts and Analysis - By Application
    11.4.6 Middle East and Africa Anticoagulants Market Forecasts and Analysis - By Distribution Channel
    11.4.7 Middle East and Africa Anticoagulants Market Forecasts and Analysis - By Countries
    11.4.7.1 South Africa Anticoagulants Market
    11.4.7.1.1 South Africa Anticoagulants Market by Drug Class
    11.4.7.1.2 South Africa Anticoagulants Market by Route Of Administration
    11.4.7.1.3 South Africa Anticoagulants Market by Application
    11.4.7.1.4 South Africa Anticoagulants Market by Distribution Channel
    11.4.7.2 Saudi Arabia Anticoagulants Market
    11.4.7.2.1 Saudi Arabia Anticoagulants Market by Drug Class
    11.4.7.2.2 Saudi Arabia Anticoagulants Market by Route Of Administration
    11.4.7.2.3 Saudi Arabia Anticoagulants Market by Application
    11.4.7.2.4 Saudi Arabia Anticoagulants Market by Distribution Channel
    11.4.7.3 U.A.E Anticoagulants Market
    11.4.7.3.1 U.A.E Anticoagulants Market by Drug Class
    11.4.7.3.2 U.A.E Anticoagulants Market by Route Of Administration
    11.4.7.3.3 U.A.E Anticoagulants Market by Application
    11.4.7.3.4 U.A.E Anticoagulants Market by Distribution Channel
    11.4.7.4 Rest of Middle East and Africa Anticoagulants Market
    11.4.7.4.1 Rest of Middle East and Africa Anticoagulants Market by Drug Class
    11.4.7.4.2 Rest of Middle East and Africa Anticoagulants Market by Route Of Administration
    11.4.7.4.3 Rest of Middle East and Africa Anticoagulants Market by Application
    11.4.7.4.4 Rest of Middle East and Africa Anticoagulants Market by Distribution Channel
    11.5. SOUTH AND CENTRAL AMERICA
    11.5.1 South and Central America Anticoagulants Market Overview
    11.5.2 South and Central America Anticoagulants Market Forecasts and Analysis
    11.5.3 South and Central America Anticoagulants Market Forecasts and Analysis - By Drug Class
    11.5.4 South and Central America Anticoagulants Market Forecasts and Analysis - By Route Of Administration
    11.5.5 South and Central America Anticoagulants Market Forecasts and Analysis - By Application
    11.5.6 South and Central America Anticoagulants Market Forecasts and Analysis - By Distribution Channel
    11.5.7 South and Central America Anticoagulants Market Forecasts and Analysis - By Countries
    11.5.7.1 Brazil Anticoagulants Market
    11.5.7.1.1 Brazil Anticoagulants Market by Drug Class
    11.5.7.1.2 Brazil Anticoagulants Market by Route Of Administration
    11.5.7.1.3 Brazil Anticoagulants Market by Application
    11.5.7.1.4 Brazil Anticoagulants Market by Distribution Channel
    11.5.7.2 Argentina Anticoagulants Market
    11.5.7.2.1 Argentina Anticoagulants Market by Drug Class
    11.5.7.2.2 Argentina Anticoagulants Market by Route Of Administration
    11.5.7.2.3 Argentina Anticoagulants Market by Application
    11.5.7.2.4 Argentina Anticoagulants Market by Distribution Channel
    11.5.7.3 Rest of South and Central America Anticoagulants Market
    11.5.7.3.1 Rest of South and Central America Anticoagulants Market by Drug Class
    11.5.7.3.2 Rest of South and Central America Anticoagulants Market by Route Of Administration
    11.5.7.3.3 Rest of South and Central America Anticoagulants Market by Application
    11.5.7.3.4 Rest of South and Central America Anticoagulants Market by Distribution Channel

    12. INDUSTRY LANDSCAPE
    12.1. MERGERS AND ACQUISITIONS
    12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
    12.3. NEW PRODUCT LAUNCHES
    12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

    13. ANTICOAGULANTS MARKET, KEY COMPANY PROFILES
    13.1. BRISTOL-MYERS SQUIBB COMPANY
    13.1.1. Key Facts
    13.1.2. Business Description
    13.1.3. Products and Services
    13.1.4. Financial Overview
    13.1.5. SWOT Analysis
    13.1.6. Key Developments
    13.2. GLAXOSMITHKLINE PLC.
    13.2.1. Key Facts
    13.2.2. Business Description
    13.2.3. Products and Services
    13.2.4. Financial Overview
    13.2.5. SWOT Analysis
    13.2.6. Key Developments
    13.3. PFIZER, INC.
    13.3.1. Key Facts
    13.3.2. Business Description
    13.3.3. Products and Services
    13.3.4. Financial Overview
    13.3.5. SWOT Analysis
    13.3.6. Key Developments
    13.4. SANOFI
    13.4.1. Key Facts
    13.4.2. Business Description
    13.4.3. Products and Services
    13.4.4. Financial Overview
    13.4.5. SWOT Analysis
    13.4.6. Key Developments
    13.5. ASPEN HOLDINGS
    13.5.1. Key Facts
    13.5.2. Business Description
    13.5.3. Products and Services
    13.5.4. Financial Overview
    13.5.5. SWOT Analysis
    13.5.6. Key Developments
    13.6. JANSSEN PHARMACEUTICALS, INC
    13.6.1. Key Facts
    13.6.2. Business Description
    13.6.3. Products and Services
    13.6.4. Financial Overview
    13.6.5. SWOT Analysis
    13.6.6. Key Developments
    13.7. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    13.7.1. Key Facts
    13.7.2. Business Description
    13.7.3. Products and Services
    13.7.4. Financial Overview
    13.7.5. SWOT Analysis
    13.7.6. Key Developments
    13.8. DAIICHI SANKYO COMPANY, LIMITED
    13.8.1. Key Facts
    13.8.2. Business Description
    13.8.3. Products and Services
    13.8.4. Financial Overview
    13.8.5. SWOT Analysis
    13.8.6. Key Developments
    13.9. ALEXION PHARMACEUTICALS, INC
    13.9.1. Key Facts
    13.9.2. Business Description
    13.9.3. Products and Services
    13.9.4. Financial Overview
    13.9.5. SWOT Analysis
    13.9.6. Key Developments
    13.10. BAYER AG
    13.10.1. Key Facts
    13.10.2. Business Description
    13.10.3. Products and Services
    13.10.4. Financial Overview
    13.10.5. SWOT Analysis
    13.10.6. Key Developments

    14. APPENDIX
    14.1. ABOUT THE INSIGHT PARTNERS
    14.2. GLOSSARY OF TERMS
    The List of Companies

    - Bristol-Myers Squibb Company
    - GlaxoSmithKline plc.
    - Pfizer, Inc.
    - Sanofi
    - Aspen Holdings
    - Janssen Pharmaceuticals, Inc
    - Boehringer Ingelheim International GmbH
    - DAIICHI SANKYO COMPANY, LIMITED
    - Alexion Pharmaceuticals, Inc
    - Bayer AG
    - Sun Pharmaceuticals
    - Dr. Reddy's Laboratories Ltd
    - Abbott
    TIPRE00004062
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market




    Have a question?

    Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.


    Speak To Analyst
    Pricing
    • $3000
    • $4550
    • $6550
    • $8550
        GET FREE SAMPLE PDF

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount